Format

Send to

Choose Destination
Nat Rev Neurosci. 2018 Jul;19(7):383-384. doi: 10.1038/s41583-018-0012-5.

Transition to chronic pain: opportunities for novel therapeutics.

Author information

1
The University of Texas at Dallas, Richardson, TX, USA. Theodore.price@utdallas.edu.
2
University of California, San Francisco, San Francisco, CA, USA.
3
National Fibromyalgia and Chronic Pain Association, Logan, UT, USA.
4
Laval University & CERVO Brain Research Centre, Qu├ębec, QC, Canada.
5
Harvard University, Boston, MA, USA.
6
Duke University, Durham, NC, USA.
7
York University, Toronto, ON, Canada.
8
University of Texas MD Anderson Cancer Center, Houston, TX, USA.
9
National Institutes of Health, Bethesda, MD, USA.
10
University of Iowa, Iowa City, IA, USA.
11
University of Washington, Seattle, WA, USA.
12
University of Colorado, Boulder, CO, USA.
13
University of California, San Diego, San Diego, CA, USA.
14
University of Rochester, Rochester, NY, USA.
PMID:
29765159
PMCID:
PMC6237656
DOI:
10.1038/s41583-018-0012-5
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center